Navigation Links
Nutrition21 Announces the Adoption of CertainT® - a Technology That Protects the Dietary Supplement Industry and Consumers

The dietary supplement industry now has a state-of-the-art solution for ensuring supply chain transparency and reassuring consumers that what’s listed on an ingredient panel is actually in their product. As a developer of patented and trademarked ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is designed to protect the intellectual property (IP) of ingredient suppliers and brand owners of consumer products.

CertainT is a technology developed by Applied DNA Sciences (Applied DNA) (NASDAQ: APDN). Nutrition21 is not only using CertainT in its own ingredients, but as an added benefit to the industry, Nutrition21 has entered into an exclusive agreement with Applied DNA to represent the CertainT platform for functional ingredient suppliers and dietary supplement brand-owners as well.

CertainT is an authenticity and traceability platform with three technology pillars (Tag, Test, Track) which allows ingredients and products to be tagged with a unique molecular identifier. This identifier can then be tested for its presence as it travels throughout a global supply chain. The CertainT marker used by Nutrition21 is GRAS and can be easily added to ingredients. “The functional ingredient market follows our work in pharmaceuticals, where we believe transparency and trust are key tenets to drive consumer confidence. The CertainT platform provides Nutrition21 proof positive of their ingredients all the way through to their customers’ finished products and on to retail shelves and online stores. CertainT supports Nutrition21’s investment in brand and IP protection for its ingredients and its customers’ final products,” said Dr. James Hayward, president and CEO, Applied DNA.

Nitrosigine® is the first Nutrition21 product to utilize the CertainT technology. Nitrosigine can only be formulated into end products by contract manufacturers and brand owners that are exclusively licensed by Nutrition21. With these licensed sales channels in place, Nutrition21 has full transparency over who is purchasing Nitrosigine. Nutrition21 will implement a comprehensive testing program that utilizes this proprietary technology to ensure that products containing Nitrosigine are delivering the promised dose to protect consumers and brand owners.

“Our team conducted a lengthy search and vetted a number of different solutions as we worked to upgrade our IP protection program. We believe the CertainT technology is a game-changer and are excited to use it in our product portfolio. It’s another step in maintaining an honest supply chain, protecting valuable IP and assuring consumers they are getting what they pay for” said Joe Weiss, President of Nutrition21.

“Nutrition21 identified a gap in supply chain transparency and sought out a solution” said Bill Levi, VP of Operations at Nutrition21. “While offering a novel technology between ‘competitors’ is not typical, we felt this was essential in affirming our goal of protecting the industry as a whole. We are offering CertainT to every ingredient manufacturer in the industry so they can also pledge to protect and maintain a safer ingredient supply chain. The addition of CertainT to the dietary supplement industry is especially important to branded ingredient manufacturers with valuable IP to protect.”

For more information on utilizing CertainT in dietary supplements and ingredients, contact


About Nutrition21
Nutrition21 is a trusted developer and supplier of novel and clinically substantiated branded ingredients for the nutritional supplement industry. With a diverse portfolio of patented health and wellness ingredients, Nutrition21 provides ingredient solutions to some of the most successful dietary supplement brands in the marketplace today.

Nutrition 21 currently holds over 100 domestic and international issued and pending patents for products with highly marketable claims including: Nitrosigine®, Velositol®, Chromax®, nooLVL®, and Lepidamax®.
Innovative Ingredients. Real Results. For more information, please visit:

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Visit for more information. Follow us on Twitter and LinkedIn. Join our mailing list. Common stock listed on NASDAQ under the symbol APDN.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. R3 Medical Training Announces Next Comprehensive Stem Cell Training Course Set for March 13-14 2020 in Las Vegas
2. Shoreline Biome Announces New Asian Distribution Partnership
3. Sierra Announces NEW Line of MEMS-Based Thermal Mass Flow Controllers & Flow Meters
4. Brilliant Announces Partnership with WAVE Electronics to Offer Turnkey Smart Home Packages for Homebuilders and Multifamily Developers/Operators
5. QCDx Announces Sale of the RareScope to the Carole and Ray Neag Comprehensive Cancer Center at UConn Health for Use in Clinical Research
6. Vuja De Sciences Announces the Appointment of Two New Board Members
7. ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2020 Cohort of Life Science Startups
8. Leak Detection Associates Announces New SIMS 21 CFR Part 11 Compliant System Software
9. Leak Detection Associates Announces New SIMS 1915+ Low Temperature -80C Helium Leak Testing System
10. Silony Medical Announces First Robotic Assisted Surgery in the UK
11. Cirrascale Cloud Services Announces Availability of Graphcore IPU Servers and Cloud Instances for Machine Intelligence Workflows
Post Your Comments:
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell (hMSC) working cell banks and hMSC bioprocess systems, today announced the ... collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed ...
(Date:5/15/2020)... , ... May 15, 2020 , ... Sentien Biotechnologies, Inc., ... of Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s ... well as work closely with CEO Brian Miller and Sentien’s management team. ...
(Date:5/14/2020)... ... May 13, 2020 , ... In collaboration with Sartorius, ... in the Life Science Lab . The comprehensive information source was created for ... and liquid handling to contamination control. , The content hub features the latest ...
(Date:5/5/2020)... Pa. (PRWEB) , ... May 04, 2020 , ... ... and process solutions for the life sciences industry, today announced that Informa Training ... is officially changing its name to Red Nucleus Boston, effective immediately. , “The ...
Breaking Biology Technology:
(Date:5/21/2020)... Mass. (PRWEB) , ... May 21, 2020 , ... ... orthopedic care across the North Shore and Greater Boston area, is pleased to ... , As one of the busiest group practices in the area, Agility Orthopedics ...
(Date:5/11/2020)... (PRWEB) , ... May 11, 2020 , ... ... remote monitoring software platform for patients with implanted cardiac devices. The Octagos software ... using one portal. The software greatly simplifies the management of remote transmissions and ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
Breaking Biology News(10 mins):